Literature DB >> 876914

Sarcoma complicating therapy with cyclophosphamide.

J S Marks, C L Scholtz.   

Abstract

A patient is described who developed a poorly differentiated sarcoma after cyclophosphamide was used to treat his rheumatoid arthritis. This case emphasizes the importance ot considering neoplastic disease as a potential hazard associated with the use of immunosuppressive drugs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 876914      PMCID: PMC2496532          DOI: 10.1136/pgmj.53.615.48

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  3 in total

1.  Immunological aspects of malignant disease.

Authors:  F M Burnet
Journal:  Lancet       Date:  1967-06-03       Impact factor: 79.321

2.  Immunosurveillance and cancer: epidemiological evidence.

Authors:  R Doll; L Kinlen
Journal:  Br Med J       Date:  1970-11-14

3.  Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma).

Authors:  S F Tolchin; A Winkelstein; G P Rodnan; S F Pan; H R Nankin
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.